On Monday, a surprising by appeared on President Trump’s Truth Social feed promoting the wider use of CBD. The video, produced by the nonprofit Commonwealth Project, urged Medicare to cover medical marijuana treatments for seniors. Almost instantly, marijuana stocks soared as investors interpreted it as a major sign that federal legalization might finally be on the horizon.
Industry analysts quickly noted how significant this was. According to FundCanna CEO Adam Stettner, President Trump’s decision to share the CBD video represents “a shift in thinking from the White House.” This marks the first time a sitting president has publicly supported integrating cannabinoids into Medicare coverage—a strong signal that reform on cannabis policy could soon become reality.
The Commonwealth Project’s video praised President Trump for his role in signing the 2018 Farm Bill, which legalized hemp with less than 0.3% THC. The video described how the body’s “endocannabinoid system” weakens with age, leading to pain and stress, while suggesting that hemp-derived CBD can restore balance, reduce discomfort, and improve sleep. It concluded with a bold message: “You will deliver the most important senior health initiative of the century.”
For President Trump, the appeal is clear. The nonprofit estimates that expanding medical marijuana use could save up to $64 billion in annual healthcare costs—something that aligns perfectly with his long-standing goal of cutting federal spending. Allowing Medicare to cover medical marijuana could reduce reliance on addictive pharmaceuticals while lowering national healthcare expenses.
Investors are treating this as a major political and economic signal. Following President Trump’s post, shares of Canopy Growth jumped 17%, Aurora Cannabis rose 28%, Tilray gained 60%, and U.S.-based Curaleaf Holdings climbed over 37%. Market optimism reflects growing confidence that nationwide legalization could occur sooner rather than later.
While no official announcement has been made, political observers believe the Truth Social post may be a “trial balloon” to gauge public response. If momentum continues, President Trump could formalize his position during the upcoming State of the Union address in early 2026, potentially asking Congress to pass legislation legalizing marijuana.
Whether or not this timeline holds, one thing is clear: President Trump has opened a new chapter in the national conversation about cannabis. His actions suggest a pragmatic approach focused on senior health, cost savings, and industry growth. If legalization follows, President Trump’s move could reshape healthcare policy, investor strategies, and the broader economic landscape for years to come.